Molecular profiling identifies at least 3 distinct types of post-transplant lymphoproliferative disorder involving CNS
Here we sought to investigate the clinical, pathologic, and molecularcharacteristics of PTLD-CNS to better identify factors that may be useful to risk stratify this patient population